saxenda glp-1 diabetes market impact Industry Trends and Global Forecasts Saxenda (liraglutide) for the Treatment

Risk-Benefit Assessment : The potential benefits must be carefully weighed against known and unknown risks, particularly given the limited long-term safety data in adolescents

[DOI] [PubMed] [Google Scholar] [64].Lau J, Bloch P, Schaffer L, Pettersson I, Spetzler J, Kofoed J, Madsen K, Knudsen LB, McGuire J, Steensgaard DB, Strauss HM, Gram DX, Knudsen SM, Nielsen FS, Thygesen P, Reedtz-Runge S, Kruse T, Discovery of the Once-Weekly Glucagon-Like Peptide-1 (GLP-1) Analogue Semaglutide, Journal of medicinal chemistry, 58 (2015) 73707380

(2024, August 12)

This reordering underscores how quickly the newest weight-loss/diabetes drugs hailed as a new class of blockbusters have risen to dominance in the pharma market

GLP-1 weight loss helps treat a range of health concerns linked to excess weight, including obesity, insulin resistance, type 2 diabetes, high blood pressure, and high cholesterol

Tirzepatide, with its 5-day half-life, requires approximately 5 weeks of washout